SIGVARIS launches Phlebo-App on 150th anniversary
Around 15 per cent of the population currently suffer from venous diseases. The SIGVARIS Phlebo-App for iPad, Android and Microsoft Surface explains why these medical conditions arise and how they can be prevented and treated. “The App was tested by doctors at the World Congress of the International Union of Phlebology (UIP) in September 2013 in Boston and was very well received,” says Urs Toedtli, SIGVARIS Group CEO. “We are delighted to see this App marking another milestone in our company’s 150-year history.”
An App explains venous diseases
The SIGVARIS Phlebo-App for iPad, Android and Microsoft Surface is primarily intended as a communication tool to help doctors explain venous diseases and prevention and treatment methods to patients. It is also an information source that patients can access at any time. The App pinpoints the most important veins and places on the human body where venous diseases occur. Video clips provide a simple explanation of venous diseases, their origins and prevention as well as their treatment using medical compression stockings.
A pioneer creates value added
SIGVARIS is the world‘s leading manufacturer of high quality medical compression textiles. This 150-year old internationally successful Swiss family company is tireless in its pursuit of quality and innovation as it works to help customers improve their health and their quality of life. It developed the first effective medical compression stocking (1961), the first made-to-measure medical compression stocking (1990), and the aesthetically and medically effective “Diaphane” stocking (2001). The launch of the Phlebo-App represents another milestone for the pioneering group: a service with value added for customers, the medical profession and business partners. “The App can be used globally as an educational tool. We are currently working on other language versions,” Urs Toedtli says visibly pleased.
Available now free of charge
The SIGVARIS Phlebo-App for iPad has been available since December 2013 while the new versions for Android and Microsoft Surface can be downloaded now in five languages from the App Stores.
SIGVARIS Management AG
Corporate Communications Manager
St. Georgenstrasse 70
Phone: +41 52 265 00 81
About SIGVARIS – 150th anniversary
SIGVARIS celebrated its 150th anniversary in 2014. The Swiss company can look back at a successful track record as it moves continuously towards the future, in keeping with its motto “Every day a step further”.
The Swiss company SIGVARIS, 100% family-owned since it was founded, is the global market leader in the manufacture of medical compression stockings. The company was established in 1864 in Winterthur. For around 100 years, SIGVARIS produced “rubber-elastic textiles”, which it sold both in Switzerland and abroad. From 1958 to 1960 the company collaborated with Dr. Karl Sigg to develop a medical compression stocking to improve venous function and relieve venous-related conditions. The product portfolio was expanded in 2009 when the WELL BEING and SPORTS lines were added to the main MEDICAL line. WELL BEING stockings have a preventive function and relieve the early symptoms of leg conditions while SPORTS products improve athlete performance and recovery time. Today SIGVARIS has 240 employees in Switzerland and its customers include pharmacies, chemists, orthopaedic and medical specialist stores as well as doctors and hospitals.
The Winterthur-based group has 1,400 employees worldwide and incorporates its own quality-guaranteed production plants in Switzerland, France, Brazil and the US as well as wholly-owned subsidiaries in Germany, Austria, UK, Canada, China, Australia, Mexico and the United Arab Emirates. These supply around 70 countries globally. SIGVARIS Group pursues an international growth strategy, which is driven by successful leverage of core competencies, strengthening of the WELL BEING and SPORTS lines and continuous expansion of its international presence. The Group produced about 8 million pairs of stockings in 2014 and generated revenue of around CHF 250 million. www.sigvaris.com